Key takeaways
- Johnson and Johnson revealed lower earnings and sales numbers than expected in Q4 2022
- Even before Q4 numbers were released, JNJ started falling after a slew of new stories hit the press
- Even though 2022 was a turbulent year for this household name, Johnson and Johnson’s financials are still solid
Johnson and Johnson’s stock has taken a tumble this month. Share prices are down from their peak of $180.25 on January 6, 2023. They hit a one-month low of $168.31 on January 24, 2023, and closed at $168.69 on January 26, 2023.
There are multiple reasons for this slip, from reduced demand for the J&J vaccine to a disappointing reveal of recent earnings numbers for Q4 2022.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased